AGN

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Is a Good Spec Buy

By Dana Blankenhorn, InvestorPlace Contributor
Teva Pharmaceutical (TEVA) needs the right leadership and a new strategy, but assets make TEVA stock enticing as a gamble.

3 Drug Stocks Hit by Trump’s Call for Lower Prices

By Anthony Mirhaydari, InvestorPlace Market Strategist
While stocks in general are looking weak, pharmaceutical stocks in particular are getting hit. Here are three large-cap drug stocks to avoid.

Teva Pharmaceuticals Industries Ltd (ADR) (TEVA): Be Cautious and Earn a Double-Digit Return

By Chris Tyler, InvestorPlace Contributor
There’s reasons to see Teva Pharmaceuticals (TEVA) as attractively priced, but a credit put spread trumps owning TEVA stock for the time being.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is CRAZY Cheap

By Vince Martin, InvestorPlace Contributor
Teva Pharmaceutical's (TEVA) turnaround hopes and cheap multiple are attractive right now. TEVA stock has risks, but the reward is tempting.

Zeltiq Aesthetics Inc (ZLTQ) Stock Soars on$2.5B Allergan (AGN) Deal

By William White, InvestorPlace Writer
Zeltiq Aesthetics Inc (ZLTQ) stock was up on Monday following news that Allergan plc Ordinary Shares (AGN) will acquire it.

Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock: Will the Slump End?

By Chris Lau, InvestorPlace Contributor
The flood of Teva Pharmaceutical's (TEVA) bad news, such as a CEO departure and patent case loses, just keep pummeling TEVA stock.

Trade of the Day: Teva Pharmaceuticals (NYSE:TEVA)

By John Jagerson and Wade Hansen
TEVA has been in a steady downtrend for nearly a year and a half, and we don’t think the bearish move is over.

10 Dividend Growth Stocks That Simply Print Money

By Brian Bollinger, Simply Safe Dividends
Investors who buy these dividend growth stocks today will reap decent yields now ... but downright excellent income in the future.

Is Allergan plc Ordinary Shares (AGN) Snapping Out of It?

By InvestorPlace Research Staff
Allergan (AGN) has been riding a long-term downtrend. However, the tides are turning, and AGN is making a serious run at a reversal.

3 Stocks That Could Get Pounded by Tax Loss Selling

By Wayne Duggan, InvestorPlace Contributor
Tax loss selling could drive some of the worst stocks of the year -- including TRIP, AGN and FSLR -- even lower before year's end.

The 10 Biggest Stock Market Failures of 2016 

By Will Ashworth, InvestorPlace Contributor
There weren’t too many stock market horror stories in 2016 but these 10 stocks definitely had a hard time winning investors’ affections.

The 10 Best Healthcare Stocks to Buy for 2017

By James Brumley, InvestorPlace Feature Writer
These are the 10 best healthcare stocks to buy going forward after the 2016 presidential election shook up the whole sector.

26 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader
The ratings of 26 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Biotech Stocks You MUST Buy for Donald Trump’s Presidency

By Chris Tyler, InvestorPlace Contributor
Biotech stocks like REGN, BIIB and CELG received a Trump card, but bulls may want to buy into a pullback using these options spreads.

Valeant Pharmaceuticals Intl Inc (VRX) Stock Enters ‘Survivor Mode’

By Dana Blankenhorn, InvestorPlace Contributor
Valeant Pharmaceuticals (VRX) has to sell the family silver to pay debts, and its business model is under attack. VRX stock might not make it.

14 Pharmaceuticals Stocks to Sell Now

By Portfolio Grader
This week, the ratings of 14 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Why Valeant Pharmaceuticals Intl Inc (VRX), Allergan plc Ordinary Shares (AGN) and FleetCor Technologies, Inc. (FLT) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer
Owners of FleetCor Technologies (FLT), Valeant Pharmaceuticals (VRX) and Allergan (AGN) weren't thrilled with Wednesday's action.

3 Beaten-Down Healthcare Stocks to Buy

By Ryan Fuhrmann, InvestorPlace Contributor
Allergan (AGN), Zimmer Biomet (ZBH) and McKesson (MCK) are three bona fide leaders in their respective healthcare industries.

2 Bullish Biotech Trades to Take Your Mind off the Election (BIIB CELG)

By Chris Tyler, InvestorPlace Contributor
Constructive charts and earnings reports should benefit both Biogen (BIIB) stock and Celgene (CELG) in the weeks ahead.
Load More